Veracity found its next business in a bottle

Before Veracity sold a supplement for metabolism, its founder had a problem with her skin. Allie Egan had worked in beauty and led Cynthia Rowley. Yet the dry patches that bothered her had resisted the familiar explanations. During her fertility journey, she was diagnosed with Hashimoto’s, an autoimmune condition affecting the thyroid. In her account, a complaint on the surface belonged to a larger health story. The bathroom cabinet had been asking the wrong question.

The skin complaint that sent Egan elsewhere

Egan’s experience supplied Veracity with its organizing idea: investigate what sits behind the symptom. The company’s public story emphasizes functional medicine and her search for an explanation that connected her difficulties. It is a personal account, rather than evidence that buying a supplement reproduces her outcome. Still, it explains why a former beauty executive would build a business around what happens beneath the skin.

Veracity reached customers in 2021 with an at-home hormone test and skincare. The original premise was unusually literal: collect saliva, examine hormones, then recommend a routine. Beauty shopping acquired a laboratory step. In a market accustomed to promising that the right jar would solve the problem, Veracity asked customers to consider whether the jar was answering the whole question.

The customer edited the business plan

The pivot came from a second kind of evidence: customers. In a July 2026 interview, Egan recalled roughly 10,000 hormone-test users. Their results and symptom surveys suggested an opportunity in metabolism and weight management. A test designed to explain individual experiences was also helping the company see a pattern across them.

Metabolism Ignite arrived in October 2023. Egan says that within two months its revenue exceeded the rest of the company’s combined. That response gave the team a reason to concentrate on metabolic health. The decision was unsentimental. A founder can cherish the first idea; customers remain free to prefer the next one.

“the revenue from that one product dwarfed everything else”

Allie Egan, Reclaim, 2026

Notice the sequence. The company first asked customers to describe and measure something personal, then offered a product around a recurring concern. That is more informative than a fashionable category name alone. For another founder, the useful move is to pair what customers say with what they purchase. Neither kind of evidence should be allowed to bully the other into silence.

A shopping basket built around metabolism

Today, Ignite is the anchor of a broader wellness catalog. It contains Metabolaid, a blend of hibiscus and lemon verbena extracts, plus caffeine-free green coffee bean extract and magnesium. Veracity markets it for appetite, energy, and weight support. Its directions call for two capsules before the first meal. This is a consumer routine that requires neither an injection nor a prescription.

The company also sells Metabolic Power Protein, with 20 grams of plant-based protein per two-scoop serving. Pea, pumpkin seed, and chia supply the protein; a chromium-and-amylopectin complex called MyoVera accompanies it. Other products address stress, gut health, fatigue, and perimenopause. Bundles turn those concerns into shopping categories, giving the catalog a practical vocabulary beyond the rather grand word “metabolism.”

The Hormone Wellness Test remains. Its saliva sample covers estrogen, progesterone, testosterone, DHEA, and cortisol, with personalized recommendations and a consultation. Customers can also buy nutrition sessions. That combination makes Veracity part supplement shop, part explanation service: the bottle is tangible, but understanding what to do next is part of the attraction.

Nutrition guidance costs $40 for 15 minutes, $75 for half an hour, or $150 for an hour. Through a Truemed partnership, qualified customers can pursue HSA/FSA purchases after provider review. The offer suits people who want a manageable first step and some interpretation alongside it. It also requires a budget: repeated small purchases can become a substantial annual expense.

Ozempic made the conversation bigger

Veracity occupies the consumer end of metabolic health, alongside supplement brands selling gut, blood-sugar, or appetite support. Prescription weight-management treatments compete for the same attention while belonging to a different medical category. The company’s drug-free positioning gives it a clear audience: adults interested in metabolic support who prefer supplements, including customers concerned about weight and everyday energy.

The rise of GLP-1 drugs gave that audience a new language for appetite and biology. Veracity has used the comparison aggressively, including “Nature’s Ozempic” marketing. Readers should examine the step between the slogan and the science. Its research page identifies studies of key ingredients, not a demonstration that the finished product matches a prescription drug.

That distinction matters particularly for someone expecting medication-level effects, or treatment for an underlying condition. Botanical research can inform a formulation without settling every question about it. The value of presenting studies is that customers can inspect what was measured, in whom, and for how long. The comparison becomes useful when it invites scrutiny; less useful when it substitutes for it.

There is also a practical difference between information and an answer. A hormone measurement gives a customer something to discuss; it does not explain every possible source of fatigue or weight change. Likewise, a supplement catalog organizes choices without making those choices interchangeable. Veracity’s combination of products and consultations is appealing precisely because the questions can be complicated. The interpretation needs to remain as careful as the shopping experience is convenient.

The habit is the business

Veracity’s June 2025 announcement reported more than 30-fold business growth over 18 months and a $6 million financing led by Maveron and Melitas Ventures. Those are company-reported figures. It also appointed Giorgio Dell’Acqua, a cell-biology PhD with Nutrafol experience, as chief science officer. Research, new products, and customer education were the stated uses of the money.

One-time sales sit beside subscriptions and multi-month plans. The commercial logic is straightforward: a product intended for regular use benefits from regular delivery. The customer’s decision is less automatic. A routine must remain useful and affordable to deserve renewal. Attractive packaging can earn a first look; it cannot perform the work of every subsequent month.

The lesson travels beyond wellness. Look closely at the problem that brings people through the door, then notice what they actually return to buy. Veracity let a more specific demand reshape a broad original proposition. Its future depends on keeping that clarity as the catalog expands. The next business was inside the first one; customers helped point to it.